Overview
Hidetoshi Igari practices in Chiba, Japan. Igari is rated as an Experienced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are Severe Acute Respiratory Syndrome (SARS), H1N1 Influenza, COVID-19, and Pneumonia.
Their clinical research consists of co-authoring 64 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 15 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- AIDS Dementia ComplexIgari isExperienced. Learn about AIDS Dementia Complex.
- Cerebral HypoxiaIgari isExperienced. Learn about Cerebral Hypoxia.
- COVID-19Igari isExperienced. Learn about COVID-19.
- EmpyemaIgari isExperienced. Learn about Empyema.
- Fish-Eye DiseaseIgari isExperienced. Learn about Fish-Eye Disease.
- FluIgari isExperienced. Learn about Flu.